Health Care • Biotechnology: Pharmaceutical Preparations
$38.11 ▼ -0.79
(-2.03%)
MKT CAP: $4.22B • VOL: 1.08M
52W L $17 52W H $49
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$32
MEDIAN
$43
MEAN
$43
HIGH
$52
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE EWTX TAPE
EWTX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $46.11 | $43.83 | 2025-02-14 | $34.68 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $48.02 | $44.97 | 2025-02-06 | $35.82 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $43.45 | $41.92 | 2025-01-29 | $36.59 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $38.87 | — | 2025-01-17 | $37.35 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $33.54 | $36.20 | 2025-01-09 | $33.92 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $45.35 | $39.63 | 2024-12-18 | $33.16 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $36.97 | $38.49 | 2024-12-04 | $35.44 | -4.3% | 48% | C |